HEALTH TECHNOLOGY

DeepIntent® introduces DeepIntent Outcomes

DeepIntent | April 07, 2021

DeepIntent, the leading healthcare marketing technology company built to influence patient health and business outcomes, today announced DeepIntent Outcomes, which uses real-world clinical evidence to significantly boost script lift attributed to digital advertising. DeepIntent Outcomes, which is built into its Healthcare Demand-Side Platform (DSP), allows advertisers to measure and automatically optimize live promotions based on script performance from pharmaceutical claims data that is updated regularly.

 

DeepIntent Outcomes assists healthcare marketers in solving today's common barriers, such as data silos, the use of multiple channels, and delayed reporting. DeepIntent Outcomes enables marketers to use script performance to reduce waste, improve marketing mix in-flight and:

 

  • Plan their strategies focused on insights into patients' and providers' in-market behaviors.
  • Enable their media plans for all devices via a single platform;
  • Monitor the effects of each campaign in real-time
  • Optimize campaign efficiency regularly by automatically modifying creative, reach, frequency, publishers, pricing, and bidding strategy.

 

DeepIntent Outcomes promotes the ability to measure the combined impact of patient and provider advertisement on script lift as one of the strategic use cases. DeepIntent Outcomes partnered with Publicis Health Media to coordinate and measure ad exposures to patients and caregivers with one of their leading pharmaceutical clients. Through this new platform, their client's script lift has increased by an average of 10-35 %.

 

Through its collaboration with Komodo Health, DeepIntent Outcomes has access to the industry's most comprehensive, transparent, trusted, and verified healthcare data set, as well as the fastest pharmaceutical data refresh. DeepIntent's healthcare identification graph sees 75% of healthcare providers every day and 86% every month, with a 25% higher overall audience quality for patient campaigns. The combination of these two solutions provides previously unseen capabilities in the pharmaceutical market. DeepIntent was named Best-Buy Side Programmatic Platform by Digiday in 2020, beating out rivals such as Xandr and Verizon Media.

 

About DeepIntent

DeepIntent, founded by former Memorial Sloan Kettering data scientists, connects healthcare companies with patients and providers through all devices through proprietary data, media collaborations, and integrations. DeepIntent is seen to increase script lift while enhancing patients' quality of life from across the board, from campaign planning to audience targeting to measuring and maximizing. Its Healthcare Marketing Platform enables marketers at seven of the top ten pharmaceutical companies and major healthcare advertising agencies to have a direct impact on health and business outcomes.

Spotlight

Managing denials and collecting patient payments are the two most significant operational challenges faced by hospitals. Heading into 2019 and thinking about your hospital's financial priorities, what are the biggest Revenue Cycle challenges for your hospital? Days in A/R is the most frequently used metric by hospitals of all sizes to measure revenue cycle management (RCM) performance.


Other News
HEALTH TECHNOLOGY

Walmart To Acquire AR Optical Tech Company Memomi

Walmart and Memomi | June 30, 2022

Walmart and Memomi, an augmented reality optical tech companyannounced they have entered into an agreement for Walmart to acquire Memomi. This reinforces Walmart’s commitment to frictionless and omnichannel optical care. Since 2019, Memomi has enabled digital measurements for all Walmart and Sam’s Optical customers, across more than 2,800 Walmart Vision Centers and 550 Sam’s Clubs, and also powers the Optical eCommerce experience on SamsClub.com. Acquiring Memomi, an AR company, is the next step in Walmart’s journey of offering personalized, affordable access to optical care. This acquisition furthers Walmart Health & Wellness’ strategy to deliver integrated, omnichannel healthcare, leveraging data and technology to improve engagement, health equity and outcomes. “Customers are looking for access to care digitally, in their homes, and purchasing eyeglasses is no different. This acquisition supports our Health & Wellness mission to provide accessible care to the communities we serve.” David Reitnauer, Vice President, Specialty Services, Walmart Health & Wellness Memomi is a leading provider of technology to enhance virtual optical try-on experiences, helping customers virtually “try on” eyewear in real-time for a seamless, easy and fun omnichannel experience. “Walmart’s ability to roll out our virtual try-on and contact-free digital measurements service in a short period of time shows how committed Walmart is to its customers’ need for digital care in-stores and at home,” said Ofer Saban, Chief Technology Officer, Memomi. The acquisition is expected to close in the coming weeks, and Memomi employees will join the Walmart Global Tech organization. “We’re excited to welcome the Memomi team to Walmart and add their capabilities to our leading virtual reality technology that is transforming the retail experience for our customers and members,” said Cheryl Ainoa, Senior Vice President, New Businesses & Emerging Tech, Walmart Global Tech. “We are looking forward to joining Walmart and offering our innovations and user experiences to such a large scale both in-store and online,” said Salvador Nissi Vilcovsky, CEO, Memomi. About Walmart Walmart Inc. helps people around the world save money and live better - anytime and anywhere - in retail stores, online, and through their mobile devices. Each week, approximately 220 million customers and members visit approximately 10,500 stores and clubs under 48 banners in 24 countries and eCommerce websites. With fiscal year 2021 revenue of $559 billion, Walmart employs over 2.2 million associates worldwide. Walmart continues to be a leader in sustainability, corporate philanthropy and employment opportunity. About Memomi Memomi Labs Inc is a leading provider of cutting-edge technology to enhance virtual try-on user experiences through artificial intelligence, deep learning and augmented reality. Memomi helps customers virtually “try on” eyewear in real-time for a seamless, easy and fun omnichannel experience. In addition to the try-on experience, Memomi technology has created an accurate, easy measurement experience in-store once glasses are selected, leading to time savings for the customer and cost savings for the store. Memomi was founded in 2014 by Salvador Nissi Vilcovsky and Ofer Saban, experts in conceptualized solutions and interactive design.

Read More

HEALTH TECHNOLOGY

NUTEX HEALTH ANNOUNCES TWO NEW FULLY FUNCTIONAL MICRO HOSPITALS

Nutex Health, Inc. | May 17, 2022

Nutex Health Inc. a physician-led, technology-enabled healthcare services company comprised of a hospital division with 21 facilities in 8 states and a primary care-centric, risk-bearing population health management division, announced two new fully operational micro hospitals. The first hospital, New Braunfels ER & Hospital, is in New Braunfels, Texas, located about 30 miles northeast of San Antonio. The state-of-the-art facility is open 24/7, 365 days a year, and includes an emergency room with 9 private exam rooms staffed with board-certified physicians and 4 private inpatient beds. The hospital provides both adult and pediatric care, and has the most advanced imaging and laboratory equipment, including CT, X-Ray and ultrasound with rapid radiological reports. The second hospital, East Valley ER & Hospital, is in Gilbert, Arizona, located about 21 miles southeast of Phoenix. The state-of-the-art hospital is open 24/7, 365 days a year, and includes an emergency room with 14 private exam rooms and 14 private inpatient beds. The hospital provides both adult and pediatric care, and has the most advanced imaging and laboratory equipment, including MRI, CT, X-Ray and ultrasound. Nutex currently anticipates opening 3 more facilities in 2022, with another 17 facilities either under construction or in advanced planning stages and anticipated to open in 2023 and 2024. There can be no assurance that these additional facilities will open in the anticipated timing or that they will open at all. Nutex micro hospitals focus on ensuring that patients receive a premium patient experience. Our hospitals feature short ER wait times averaging 15 minutes from entering the door to seeing a physician, high-quality care, lower nursing- and physician-to-patient staffing ratios and faster discharge times. Physicians, nurses and other employees are incentivized to provide quality, compassionate care to their patients. Nutex micro hospitals consistently have better outcomes and high patient satisfaction scores, with well over 1000 five-star Google reviews. "We are excited to continue to expand Nutex's network of micro hospitals across the country. Both New Braunfels and Gilbert are vibrant and rapidly growing suburbs of major metropolitan areas. Our goal is to provide high-quality acute medical care to the populations of these communities." Tom Vo, M.D., MBA, Chairman and Chief Executive Officer of Nutex Health "Entering the medical field, my goal was always to try to revolutionize the way healthcare is delivered to our patients. Our unique model allows physicians and nurses to retake control of patient care," stated Trey Allen, M.D., Medical Director at New Braunfels ER & Hospital. "We are committed to working with the community to make sure they can receive the healthcare they deserve." "As physicians, we saw how healthcare was being delivered, and we felt we could do better. We felt the humanity and compassion were absent from many medical interactions. We value and respect our patients, and treat them as family," stated Daniel Stites, M.D., Medical Director at East Valley ER & Hospital. About Nutex Health Inc. Headquartered in Houston, Texas and founded in 2011, Nutex Health Inc. is a physician-led, technology-enabled healthcare services company with approximately 1500 employees nationwide and is partnered with over 800 physicians. The Company has two divisions a Hospital division and a Population Health Management division. The hospital division owns and operates 21 facilities in eight different states. The division implements and operates different innovative health care models, including micro hospitals, specialty hospitals and hospital outpatient departments. The Population Health Management division owns and operates provider networks such as Independent Physician Associations (IPAs). Through our Management Services Organizations, we provide management, administrative and other support services to our affiliated hospitals and physician groups. Our cloud-based proprietary technology platform aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers, allowing us to deliver greater quality care more efficiently. Safe Harbor Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Federal Private Securities Litigation Act of 1995. When used in this press release, the words or phrases "will", "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intend," "goal," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include the ability to realize the anticipated benefits of the transaction, significant transaction costs and unknown liabilities and litigation and regulatory risks related to the transaction. In addition, forward-looking statements are subject to additional uncertainties and risks facing the Company, including but not limited to, economic conditions, dependence on management, dilution to stockholders, lack of capital, changes in laws or regulations, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release.

Read More

FUTURE OF HEALTHCARE

WELL Health Enters into Automatic Share Purchase Plan

WELL Health Technologies Corp. | June 16, 2022

WELL Health Technologies Corp.ca company focused on positively impacting health outcomes by leveraging technology to empower practitioners and their patients globally, announced today that it has entered into an automatic share purchase plancwith a broker in order to facilitate repurchases of the Company's common shares under its previously announced normal course issuer bid. WELL previously announced that it had received approval from the Toronto Stock Exchange to, during the 12-month period commencing June 1, 2022 and terminating May 31, 2023, purchase up to 5,555,386 Common Shares, representing approximately 2.5% of the 222,215,443 Common Shares issued and outstanding as of May 30, 2022, by way of a NCIB on the TSX or through alternative trading systems or by such other means as may be permitted under applicable law. During the effective period of WELL's ASPP, WELL's broker may purchase Common Shares at times when WELL would not be active in the market due to insider trading rules and its own internal trading blackout periods. Purchases will be made by WELL's broker based upon parameters set by WELL when it is not in possession of any undisclosed material information about itself and its securities, and in accordance with the terms of the ASPP. Outside of the effective period of the ASPP, Common Shares may continue to be purchased in accordance with WELL's discretion, subject to applicable law. The ASPP has been entered into in accordance with the requirements of applicable Canadian securities laws. About WELL Health Technologies Corp. WELL is a practitioner focused digital healthcare company whose overarching objective is to positively impact health outcomes to empower and support healthcare practitioners and their patients. WELL has built an innovative practitioner enablement platform that includes comprehensive end to end practice management tools inclusive of virtual care and digital patient engagement capabilities as well as Electronic Medical Records (EMR), Revenue Cycle Management (RCM) and data protection services. WELL uses this platform to power healthcare practitioners both inside and outside of WELL's own omni-channel patient services offerings. As such, WELL owns and operates Canada's largest network of outpatient medical clinics serving primary and specialized healthcare services and is the provider of a leading multinational, multi-disciplinary telehealth offering. WELL is publicly traded on the Toronto Stock Exchange under the symbol "WELL" and is part of the TSX Composite Index. The Company also trades on the OTCQX Markets under the symbol "WHTCF".

Read More

FUTURE OF HEALTHCARE

Spectrum Science Acquires The Seismic Collaborative, Deepening Expertise in Emerging Innovation and Health Technology

Spectrum Science | June 10, 2022

Spectrum Science, an independent, integrated marketing, communications and media agency hyper-focused on health and science, announced the acquisition of The Seismic Collaborative, an independent health and life science agency that specializes in supporting early-stage health tech and biotech companies. The Seismic acquisition establishes the Emerging Innovation Group within Spectrum, a new offering that expands the agency's capabilities to deliver at all points of a company and product lifecycle. "We're delighted to welcome Seismic's incredible talent and expertise to the Spectrum team," says Jonathan Wilson, Owner and CEO of Spectrum. "For the past several years, we've worked to strategically diversify talent and capabilities within our agency, to keep pace with client needs in a rapidly evolving industry—including the burgeoning biotech and health tech sectors. With today's acquisition, we're now able to broaden the scope of clients we support, bringing a flexible model and approach to service both early-stage and start-up clients as well as those who are more established." This new venture brings seasoned leaders with extensive experience and current business in emerging innovation and health technology to the Spectrum team, including Seismic CEO, Lisa Rodriguez, who will serve as the President of the Emerging Innovation Group within Spectrum and will play a lead role within the company's existing Health Tech practice. "Becoming a part of the Spectrum organization strengthens Seismic's connection to clients who are growing, expanding and advancing innovation in the health tech and life science sectors. Now more than ever before, emerging companies require end-to-end, global capabilities to reach their hypergrowth goals—Spectrum is the perfect place to make that happen. Our new home provides a dynamic and vibrant extension of our services where we can evolve with our client partners throughout their lifecycle." Seismic CEO Lisa Rodriguez Also joining the Spectrum organization from Seismic are EVPs Melissa Laverty and Vikki Herrera, along with Seismic's full team of strategists, writers and earned and social media specialists. Today's announcement builds on the recently announced acquisition of SONIC Health, the first deal of its kind for Spectrum in the company's 26-year history. Financing for both acquisitions was provided by Monroe Capital. About The Seismic Collaborative The Seismic Collaborative communicates the stories of the people, products and services that transform healthcare and save lives through a range of strategy, media relations, content and social media services. The Seismic Collaborative's model rejects traditional PR agency norms, focusing instead on high-touch, deeply engaged, collaborative partnerships that are structured upon the results achieved. To learn more, visit www.teamseismic.com. About Spectrum Science Spectrum Science is an integrated marketing, communications and media agency like no other. An independent, full-service agency with end-to-end capabilities, Spectrum's team are experts in science—focused on strategic engagements with our audiences. We leverage human-centered insights, motivating creative, innovative storytelling and technology to reach audiences where they are with the content they need and want. Spectrum offers global reach as the US partner and chair of Global Health Marketing & Communications (GHMC).

Read More

Spotlight

Managing denials and collecting patient payments are the two most significant operational challenges faced by hospitals. Heading into 2019 and thinking about your hospital's financial priorities, what are the biggest Revenue Cycle challenges for your hospital? Days in A/R is the most frequently used metric by hospitals of all sizes to measure revenue cycle management (RCM) performance.

Resources